Evgen Pharma PLC (AIM:EVG) CEO Dr Huw Jones speaks to Proactive to talk through the company's interim results.
Jones talks about what he considers the highlights from the first half-year and says that Evgen's "cash runway is in pretty good shape" with funding in place for at least the next two years.